Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
Enrolling By Invitation
18-99 years
All
Phase
1
15 participants needed
1 Location
Brief description of study
The primary outcomes will be to establish the safety and feasibility of inhaled imaging in patients with NSCLCand to develop a robust RT planning protocol incorporating both standard of care metrics and those derived from inhaled imaging
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research,non-small cell lung carcinoma (NSCLC)
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 849026
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
